Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,098 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Evaluating police drug diversion in England: protocol for a realist evaluation.
Stevens A, Hendrie N, Bacon M, Parrott S, Monaghan M, Williams E, Lewer D, Moore A, Berlin J, Cunliffe J, Quinton P. Stevens A, et al. Among authors: berlin j. Health Justice. 2023 Nov 16;11(1):46. doi: 10.1186/s40352-023-00249-2. Health Justice. 2023. PMID: 37968494 Free PMC article.
Executive Summary of the American Radium Society® (ARS) Appropriate Use Criteria (AUC) for Non-Operative Management (NOM) for Rectal Adenocarcinoma: Systematic Review and Guidelines.
Anker CJ, Tchelebi L, Selfridge JE, Jabbour SK, Akselrod D, Cataldo P, Abood G, Berlin J, Hallemeier CL, Jethwa KR, Kim E, Kennedy T, Lee P, Sharma N, Small W Jr, Williams VM, Russo S. Anker CJ, et al. Among authors: berlin j. Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00673-4. doi: 10.1016/j.ijrobp.2024.05.019. Online ahead of print. Int J Radiat Oncol Biol Phys. 2024. PMID: 38797496 Review.
The Academic Payvider Model: Commentary.
Berlin JM. Berlin JM. Popul Health Manag. 2024 May 6. doi: 10.1089/pop.2024.0058. Online ahead of print. Popul Health Manag. 2024. PMID: 38708955 No abstract available.
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutations.
Rodon J, Rodriguez E, Maitland ML, Tsai FY, Socinski MA, Berlin JD, Thomas JS, Al Baghdadi T, Wang IM, Guo C, Golmakani M, Clark LN, Gazdoiu M, Li M, Tolcher AW. Rodon J, et al. Among authors: berlin jd. ESMO Open. 2024 Apr;9(4):102961. doi: 10.1016/j.esmoop.2024.102961. Epub 2024 Apr 18. ESMO Open. 2024. PMID: 38640748 Free PMC article. Clinical Trial.
Prediction Models and Clinical Outcomes-A Call for Papers.
Fihn SD, Berlin JA, Haneuse SJPA, Rivara FP. Fihn SD, et al. Among authors: berlin ja. JAMA Netw Open. 2024 Apr 1;7(4):e249640. doi: 10.1001/jamanetworkopen.2024.9640. JAMA Netw Open. 2024. PMID: 38607631 Free article. No abstract available.
A phase I study of ATR inhibitor gartisertib (M4344) as a single agent and in combination with carboplatin in patients with advanced solid tumours.
Burris HA, Berlin J, Arkenau T, Cote GM, Lolkema MP, Ferrer-Playan J, Kalapur A, Bolleddula J, Locatelli G, Goddemeier T, Gounaris I, de Bono J. Burris HA, et al. Among authors: berlin j. Br J Cancer. 2024 Apr;130(7):1131-1140. doi: 10.1038/s41416-023-02436-2. Epub 2024 Jan 29. Br J Cancer. 2024. PMID: 38287179 Free PMC article. Clinical Trial.
1,098 results